Vyvanse (Shire LLC)
Welcome to the PulseAid listing for the Vyvanse drug offered from Shire LLC. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shire LLC |
| NON-PROPRIETARY NAME: | lisdexamfetamine dimesylate |
| SUBSTANCE NAME: | LISDEXAMFETAMINE DIMESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-08-30 |
| END MARKETING DATE: | 0000-00-00 |
Vyvanse HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vyvanse from Shire LLC |
| LABELER NAME: | Shire LLC |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2014-08-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59417-101_1db14768-5afe-43e2-92fb-8695d7c538de |
| PRODUCT NDC: | 59417-101 |
| APPLICATION NUMBER: | NDA021977 |
Other LISDEXAMFETAMINE DIMESYLATE Pharmaceutical Manufacturers / Labelers:
